For in vitro diagnostic use. Others Elecsys ProGRP IVD Elecsys® ProGRP CPS_000502 09 007 636 190 9 007 636 190 09007636190 9007636190 09007636190 proGRP Elecsys cobas e 100 V2 Elecsys ProGRP 07613336171622 Reagents, kits 100 tests cobas e 411/601/602 true 09 007 695 190 9 007 695 190 09007695190 9007695190 09007695190 proGRP Elecsys E2G 100 V2 Elecsys ProGRP 07613336199435 Reagents, kits 100 tests cobas e 402/801 true 09007636500 Elecsys ProGRP en 2 FF000000047C700E FF0000000415EB0E 09007636190 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the quantitative determination of ProGRP in human plasma and serum. The assay is used to aid in the differential diagnosis in lung cancerLREFKorse CM, Holdenrieder S, Zhi X-y, et al. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China. Clin Chim Acta 2015;438:388-395. and in the management of patients with small cell lung cancer in conjunction with other clinical methods. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 09007695500 Elecsys ProGRP en 4 FF00000004A4D30E FF0000000432CC0E 09007695190 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the quantitative determination of ProGRP in human plasma and serum. The assay is used to aid in the differential diagnosis in lung cancerLREFKorse CM, Holdenrieder S, Zhi X-y, et al. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China. Clin Chim Acta 2015;438:388-395. and in the management of patients with small cell lung cancer in conjunction with other clinical methods. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en

User profile

Select your user profile

Elecsys^® ProGRP

Overview

Ordering information

Technical documents

Compatible products

Related products

Contact us